Navigation Links
Chewable Aspirin More Readily Absorbed
Date:5/15/2009

Study suggests higher levels found in bloodstream could improve heart attack treatments

FRIDAY, May 15 (HealthDay News) -- Chewable aspirin is more readily absorbed into the bloodstream, making it the best aspirin choice for people suffering a cardiac incident, University of California, San Diego researchers report.

Volunteers who consumed chewable aspirin had higher levels of aspirin in their blood shortly afterward when compared with people who either swallowed regular aspirin whole or chewed then swallowed regular aspirin, according to the study, scheduled to be presented Friday at the Society for Academic Emergency Medicine's annual meeting in New Orleans.

Doctors sometimes prescribe aspirin to people who have had a cardiac incident or are at high risk for one.

Study abstracts also appear in the suplement to the April issue of Academic Emergency Medicine.

More information

The American Heart Association has more about using aspirin for heart conditions.



-- Kevin McKeever



SOURCE: Society for Academic Emergency Medicine, news release, May 15, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)
2. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
3. Perrigo Company Announces Final FDA Approval for OTC Famotidine Complete Chewable Tablets
4. Cavities in Children Reduced Over 60 Percent by New Experimental Chewable Mints
5. Discovery Health CME Explores the Benefits and Risks of Aspirin in Aspirin Therapy: Maximizing the Benefits
6. AUDIO from Medialink and Bayer: Is Your Pain Reliever Undermining Your Aspirin Therapy?
7. AUDIO from Medialink and Bayer: Lifesaving Benefits of Low-Dose Aspirin Therapy Maintained with Naproxen Sodium
8. New, No-Swallow Fasprin(R) Reduces Problems Associated with Daily Aspirin Regimen
9. Aspirin, Hormone Therapy Combo Can Shorten Lives of Prostate Cancer Patients
10. Aspirin Resistance Boosts Heart Risks in Cardiac Patients
11. Regular, long-term aspirin use reduces risk of colorectal cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Chewable Aspirin More Readily Absorbed
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Comfort Keepers® ... American Cancer Society and the Road To Recovery® program to drive cancer patients to ... and other adults to ensure the highest quality of life and ongoing independence. ...
(Date:6/24/2016)... ... June 24, 2016 , ... People across the U.S. ... magazine’s Code Talker Award, an essay contest in which patients and their families pay ... be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education Conference ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon and ... women in the world, and the most handsome men, look naturally attractive. Plastic ...
(Date:6/24/2016)... Maryland (PRWEB) , ... June 24, 2016 , ... ... Angels is actively feeding the Frederick area economy by obtaining investment capital for ... over the past 2½ years that have already resulted in more than a ...
(Date:6/24/2016)... ... June 24, 2016 , ... Venture Construction Group ... Tournament held on June 20th at the Woodmont Country Club at 1201 Rockville ... an organization dedicated to helping service members that have been wounded in battle and ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/24/2016)... , June 24, 2016  Global Blood ... biopharmaceutical company developing novel therapeutics for the treatment ... today announced the closing of its previously announced ... stock, at the public offering price of $18.75 ... offering were offered by GBT. GBT estimates net ...
(Date:6/24/2016)... -- Dehaier Medical Systems Ltd. (NASDAQ: DHRM ... sells medical devices and wearable sleep respiratory products in ... agreement with Hongyuan Supply Chain Management Co., Ltd. (hereinafter ... 2016, to develop Dehaier,s new Internet medical technology business. ... leverage Hongyuan Supply Chain,s sales platform to reach Dehaier,s ...
Breaking Medicine Technology: